Posts by: Margarida Azevedo

Margarida Azevedo

Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.

March 16, 2016March 16, 2016

High Coronary Calcium Score May Also Point to Risk of Cancer, Kidney and Lung Disease

A 10-year follow-up study by researchers at the Johns Hopkins University School of Medicine reported that an elevated coronary artery calcium (CAC) score, a sign of vascular aging, appears to be an accurate measure of vulnerability ... Read more

March 9, 2016April 21, 2016

Heart Disease in Women Is Focus of Cardiologist’s Study Funded by Heart to Heart Grant

University of Louisville cardiologist Andrew DeFilippis, M.D., MSc, was awarded a $100,000 Heart to Heart Grant from the Alpha Phi Foundation to study cardiovascular disease and identify a potential new biomarker ... Read more

February 10, 2016February 10, 2016

Heart Disease Network Selects Mast Therapeutics’ AIR001 for Evaluation in Clinical Trial

The Heart Failure Clinical Research Network (HFN), a group of prestigious clinical centers located across North America, has selected Mast Therapeutics’ product AIR001 for evaluation in the Phase 2 clinical ... Read more

January 20, 2016February 10, 2016

Implanted Cardiac Defibrillators Decrease Heart Failure Risk in Women

In a new study, researchers demonstrated that the use of primary prevention implantable cardiac defibrillators (ICDs) is associated with improved survival rates and decreased risk of death in women as ... Read more